Lansoprazole-associated collagenous colitis: diffuse mucosal cloudiness mimicking ulcerative colitis. 2009

Mitsuro Chiba, and Takeshi Sugawara, and Haruhiko Tozawa, and Hidehiko Tsuda, and Toru Abe, and Takuo Tokairin, and Iwao Ono, and Eriko Ushiyama
Division of Gastroenterology, Nakadori General Hospital, 3-15, Misono-cho, Minami-dori, Akita 010-8577, Japan. mchiba@meiwakai.or.jp

There have only been a few reports on lansoprazole-associated collagenous colitis. Colonic mucosa of collagenous colitis is known to be endoscopically normal. We present a case of collagenous colitis where the mucosa showed diffuse cloudiness mimicking ulcerative colitis. A 70-year-old woman developed watery diarrhea four to nine times a day. She had interstitial pneumonia at 67 and reflux esophagitis at 70 years. Lansoprazole 30 mg/d had been prescribed for reflux esophagitis for nearly 6 mo. Lansoprazole was withdrawn due to its possible side effect of diarrhea. Colonoscopy disclosed diffuse cloudiness of the mucosa which suggested ulcerative colitis. Consequently sulfasalazine 2 g/d was started. The patient's diarrhea dramatically disappeared on the following day. However, biopsy specimens showed subepithelial collagenous thickening and infiltration of inflammatory cells in the lamina propria, confirming the diagnosis of collagenous colitis. One month after sulfasalazine therapy was initiated, colonoscopic and histological abnormalities resolved completely. Five months later the diarrhea recurred. The findings on colonoscopy and histology were the same as before, confirming a diagnosis of collagenous colitis relapse. We found that the patient had begun to take lansoprazole again 3 mo ahead of the recent diarrhea. Withdrawal of lansoprazole promptly resolved the diarrhea. Endoscopic and histological abnormalities were also completely resolved, similar to the first episode. Retrospectively, the date of commencement of sulfasalazine and discontinuation of lansoprazole in the first episode was found to be the same. We conclude that this patient had lansoprazole-associated collagenous colitis.

UI MeSH Term Description Entries
D007413 Intestinal Mucosa Lining of the INTESTINES, consisting of an inner EPITHELIUM, a middle LAMINA PROPRIA, and an outer MUSCULARIS MUCOSAE. In the SMALL INTESTINE, the mucosa is characterized by a series of folds and abundance of absorptive cells (ENTEROCYTES) with MICROVILLI. Intestinal Epithelium,Intestinal Glands,Epithelium, Intestinal,Gland, Intestinal,Glands, Intestinal,Intestinal Gland,Mucosa, Intestinal
D003093 Colitis, Ulcerative Inflammation of the COLON that is predominantly confined to the MUCOSA. Its major symptoms include DIARRHEA, rectal BLEEDING, the passage of MUCUS, and ABDOMINAL PAIN. Colitis Gravis,Idiopathic Proctocolitis,Inflammatory Bowel Disease, Ulcerative Colitis Type,Ulcerative Colitis
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D046729 Colitis, Collagenous A subtype of MICROSCOPIC COLITIS, characterized by chronic watery DIARRHEA of unknown origin, a normal COLONOSCOPY but abnormal histopathology on BIOPSY. Microscopic examination of biopsy samples taken from the COLON show larger-than-normal band of subepithelial COLLAGEN. Collagenous Colitis
D053799 2-Pyridinylmethylsulfinylbenzimidazoles Compounds that contain benzimidazole joined to a 2-methylpyridine via a sulfoxide linkage. Several of the compounds in this class are ANTI-ULCER AGENTS that act by inhibiting the POTASSIUM HYDROGEN ATPASE found in the PROTON PUMP of GASTRIC PARIETAL CELLS. 2-Methylpyridine 2-Benzimidazole Sulfoxides,2-Pyridinylmethylsulfinyl-2-Benzimidazoles,Benzimidazole Methylpyridine Sulfoxides,Timoprazole Derivatives,Timoprazoles,2 Methylpyridine 2 Benzimidazole Sulfoxides,2 Pyridinylmethylsulfinyl 2 Benzimidazoles,2 Pyridinylmethylsulfinylbenzimidazoles,2-Benzimidazole Sulfoxides, 2-Methylpyridine,Methylpyridine Sulfoxides, Benzimidazole,Sulfoxides, 2-Methylpyridine 2-Benzimidazole,Sulfoxides, Benzimidazole Methylpyridine
D064747 Lansoprazole A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers. Lansoprazoles,2-(((3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl)methyl)sulfinyl)benzimidazole,AG 1749,AG-1749,Agopton,Bamalite,Lansol,Lansoprazol,Lansoprazole Sodium,Lanzor,Monolitum,Ogast,Ogastro,Opiren,Prevacid,Prezal,Pro Ulco,Promeco,Takepron,Ulpax,Zoton,AG1749,Sodium, Lansoprazole

Related Publications

Mitsuro Chiba, and Takeshi Sugawara, and Haruhiko Tozawa, and Hidehiko Tsuda, and Toru Abe, and Takuo Tokairin, and Iwao Ono, and Eriko Ushiyama
November 2001, Gastroenterologie clinique et biologique,
Mitsuro Chiba, and Takeshi Sugawara, and Haruhiko Tozawa, and Hidehiko Tsuda, and Toru Abe, and Takuo Tokairin, and Iwao Ono, and Eriko Ushiyama
February 2002, Journal of clinical gastroenterology,
Mitsuro Chiba, and Takeshi Sugawara, and Haruhiko Tozawa, and Hidehiko Tsuda, and Toru Abe, and Takuo Tokairin, and Iwao Ono, and Eriko Ushiyama
June 2008, Gastrointestinal endoscopy,
Mitsuro Chiba, and Takeshi Sugawara, and Haruhiko Tozawa, and Hidehiko Tsuda, and Toru Abe, and Takuo Tokairin, and Iwao Ono, and Eriko Ushiyama
January 2010, Endoscopy,
Mitsuro Chiba, and Takeshi Sugawara, and Haruhiko Tozawa, and Hidehiko Tsuda, and Toru Abe, and Takuo Tokairin, and Iwao Ono, and Eriko Ushiyama
July 2005, Zeitschrift fur Gastroenterologie,
Mitsuro Chiba, and Takeshi Sugawara, and Haruhiko Tozawa, and Hidehiko Tsuda, and Toru Abe, and Takuo Tokairin, and Iwao Ono, and Eriko Ushiyama
January 2009, Endoscopy,
Mitsuro Chiba, and Takeshi Sugawara, and Haruhiko Tozawa, and Hidehiko Tsuda, and Toru Abe, and Takuo Tokairin, and Iwao Ono, and Eriko Ushiyama
January 2010, Nihon Jinzo Gakkai shi,
Mitsuro Chiba, and Takeshi Sugawara, and Haruhiko Tozawa, and Hidehiko Tsuda, and Toru Abe, and Takuo Tokairin, and Iwao Ono, and Eriko Ushiyama
March 2024, Revista espanola de enfermedades digestivas,
Mitsuro Chiba, and Takeshi Sugawara, and Haruhiko Tozawa, and Hidehiko Tsuda, and Toru Abe, and Takuo Tokairin, and Iwao Ono, and Eriko Ushiyama
September 2017, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association,
Mitsuro Chiba, and Takeshi Sugawara, and Haruhiko Tozawa, and Hidehiko Tsuda, and Toru Abe, and Takuo Tokairin, and Iwao Ono, and Eriko Ushiyama
March 2013, Journal of gastrointestinal and liver diseases : JGLD,
Copied contents to your clipboard!